ロード中...
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
BACKGROUND: FibroTest and elastography have been validated as biomarkers of liver fibrosis in the most frequent chronic liver diseases and in the fibrosis screening of patients with diabetes. One challenge was to use them for estimating the prevalence of fibrosis, identifying independent risk factor...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2864202/ https://ncbi.nlm.nih.gov/pubmed/20412588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-10-40 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|